Skip to main content
. 2017 Jun 20;12(6):e0179283. doi: 10.1371/journal.pone.0179283

Table 1. Description of the population analyzed from the Enroll-HD database.

Non-HD individuals (n = 1384) HD patients (n = 5616)
No metformin (n = 1282) (No diabetes) Metformin (n = 102) (Type 2 diabetes) No metformin (n = 5456) (No diabetes) Metformin (n = 160) (Type 2 diabetes)
Genotype negative (n = 644) Family control (n = 638) Genotype Negative (n = 37) Family control (n = 65) Pre- Manifest (n = 1232) Motor- Manifest (n = 4224) Pre- Manifest (n = 39) Motor- Manifest (n = 121)
Age 45.6 (14.47) a 46 (34, 56) 56.09 (11.72) 58 (49, 64.5) 52.97 (12.92) 53 (44, 63) 61.97 (10.38) 63 (55, 69) 41.82 (11.9) 41 (33, 51) 53.32 (12.56) 54 (45, 62) 49.77 (13.05) 50 (38.5, 58) 59.39 (10.92) 59 (52, 68)
Sex Female Male 470 (73.0%) 174 (27.0%) 395 (61.9%) 243 (38.1%) 24 (64.9%) 13 (35.1%) 23 (35.4%) 42 (64.6%) 813 (66.0%) 419 (34.0%) 2198 (52.0%) 2026 (48.0%) 26 (66.7%) 13 (33.3%) 58 (47.9%) 63 (52.1%)
Body Mass Index 27.67 (6.44) 26.5 (23.4, 30.8) 28.88 (6.16) 28 (24.7, 31.6) 36.05 (8.09) 34.6 (31.6, 39) 34.04 (6.39) 32.7 (29.62, 37.78) 26.8 (5.6) 25.8 (22.75, 29.8) 25.04 (5.1) 24.3 (21.6, 27.58) 33.06 (6.54) 32.4 (28.4, 36.5) 29.5 (6.05) 28.85 (25.1, 32)
ISCED b 4.03 (1.14) 4 (3, 5) 3.89 (1.19) 4 (3, 5) 3.27 (1.41) 3 (3, 4) 3.75 (1.24) 4 (3, 5) 3.91 (1.13) 4 (3, 5) 3.37 (1.23) 3 (2, 4) 3.85 (1.11) 4 (3, 5) 3.31 (1.35) 3 (2, 5)
CAG repeats 20.22 (3.66) 19 (18, 22) 20.05 (3.41) 19 (17, 22) 20.65 (3.03) 21 (18, 22) 20.15 (3.83) 19 (17, 22) 42.29 (2.72) 42 (41, 43) 44.03 (3.95) 43 (42, 45) 40.87 (2.12) 41 (39.5, 42) 42.34 (2.33) 42 (41, 43)

a Data are presented as mean (SD) and median (1st, 3rd quartile).

b International Standard Classification of Education promoted by UNESCO to standardise.